XOMA (US) LLC (XOMA) To Humanize Attenuon, LLC's Novel Anti-Cancer Antibody
10/3/2006 4:12:50 PM
More...
|
Attenuon, LLC Names Steven D. Reich, M.D. Chief Medical Officer, Senior Vice President
10/19/2005 5:12:25 PM
More...
|
Attenuon, LLC Receives NIH Grant To Study ATN-161 Analogs As Cancer Imaging Agents
10/19/2005 5:11:59 PM
More...
|
Attenuon, LLC Announces Launch Of ATN-224 Phase I Trial In Patients With Solid Tumors
10/19/2005 5:11:28 PM
More...
|
Attenuon, LLC Release: Data From Preclinical Studies Examining Effect Of ATN-161 On Organ And Skeletal Metastases Of Breast Cancer Presented At American American Association For Cancer Research Annual Meeting
10/19/2005 5:10:36 PM
More...
|
Attenuon, LLC And Kirin Brewery Co., Ltd. (KNBWY) Of Japan Announce Joint Research Collaboration
10/19/2005 5:10:08 PM
More...
|